Effect of Three Therapeutics Strategies on Patients With a Chronic Back Pain (PLURICLEF). (PLURICLEF)

January 6, 2014 updated by: University Hospital, Angers

Effect of Three Therapeutic Strategies on the Restriction of the Participation of Patients With a Chronic Back Pain : Multidisciplinary is it the Key Component ?

Effect of three therapeutics strategies on the restriction of the participation of patients with a chronic back pain : multidisciplinary is it the key component ?

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Compare the efficacy of 1 year of participation, of three programs of care for patients with chronic law back, referred to specialists rehabilitation centers or directly to the multidisciplinary consultation of university hospital of Angers.

The primary objectif is to assess the efficacy of 1 year of the three therapeutics strategies with the number of days off work in the year following treatment.

Study Type

Interventional

Enrollment (Actual)

158

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pays de Loire
      • Angers, Pays de Loire, France, 49933
        • University Hospital of Angers, laboratory epidemiology, ergonomics and occupational health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Obtaining the signature of consent to participate in the study.
  • Male or female, aged 18-55 years.
  • Diagnosis of common chronic low back pain.
  • Chronic low back pain that led to at least a month off work in the previous year or at least 3 months of stops in the previous 2 years.
  • Employee and holds a permanent contract or a fixed-term contract in the public or private sector.

Exclusion Criteria:

  • Lack of consent to participate in the study.
  • No possibily to follow one of three programs of study
  • Pregnant women, new mothers or mothers who are breastfeeding.
  • No affiliation to the french social system.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: PLURIHOC
-Functionnal reeducation : in hospital, intensive, multidisciplinary.
Specific functionnal reeducation for chronic low back pain
Active Comparator: KIPLURI
-Functionnal reeducation : ambulatory, no intensive multidisciplinary.
Specific functionnal reeducation for chronic low back pain
Active Comparator: KIMONO
-Functionnal reeducation : ambulatory, low-intensity
Specific functionnal reeducation for chronic low back pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficiency of the 3 programs
Time Frame: One year

Compare the efficacy of 1 year of participation of the three programs of care for chronic low back pain patients referred to specialists rehabilitation centers or directly to the multidisciplinary consultation UH Angers.

The primary endpoint to assess the efficacy of 1 year of support on the participation of the patient is the number of days off work in the year following treatment.

One year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of quality of life scales
Time Frame: One year

The secondary endpoints to assess the efficacy of 1-year quality of life of the patient is the SF-36 score.

The quality of life questionnaire is collected early in the program at the end (after the 5-week program ended) at 6 months and one year.

One year
Compare the effectiveness of 1 year on improving the social integration of three programs supported in the same patients.
Time Frame: One year

The secondary endpoint to assess the efficacy of 1 year of support on improving social inclusion is the score of Dallas.

The Dallas questionnaire is collected early in the program at the end (after the 5-week program ended) at 6 months and one year.

One year
Compare the effectiveness of 1 year on physical deconditioning, three programs of care in these patients.
Time Frame: One year

The secondary endpoints to assess efficacy at 1 year of support on the physical deconditioning of the patient are the finger-floor distance, Ito test, and the test port heavy load.

These tests are performed early in the program at the end (after the program ended five weeks) at 6 months and one year.

One year
Compare the cost of 1 year from the point of view of health insurance, of the three therapeutic strategies.
Time Frame: One year
The secondary endpoints to assess the cost of 1 year from the point of view of health insurance, are the direct and indirect costs.
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Isabelle Richard-Crémieux, Md-PhD, UH Angers

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2009

Primary Completion (Anticipated)

April 1, 2014

Study Completion (Anticipated)

April 1, 2014

Study Registration Dates

First Submitted

December 19, 2013

First Submitted That Met QC Criteria

January 6, 2014

First Posted (Estimate)

January 8, 2014

Study Record Updates

Last Update Posted (Estimate)

January 8, 2014

Last Update Submitted That Met QC Criteria

January 6, 2014

Last Verified

January 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 49RC08_0014

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on functionnal reeducation

Subscribe